CERE

Cerevel Therapeutics Holdings, Inc.

No insider bought or sold Cerevel Therapeutics Holdings, Inc. in the last 12 months

$0Bought, 12 mo

$0Sold, 12 mo

Follow CERE

CERE over the last year

Prices for CERE aren't in yet.

CERE after insider buys

3 months after each buy, from the first price a copier could get.

1 buy has 3 months of prices so far. A record shows here at 3.

Every filing

62 insider filings since 2020, newest first

CERESell

N Anthony Coles · Director

$1.0M−49.0%Jul 3

CERESell

N Anthony Coles · Director

$2.0M−76.0%Jun 5

CERESell

N Anthony Coles · Director

$2.1M−76.0%May 14

CERESell

N Anthony Coles · Director

$2.1M−76.0%Apr 3

CERESell

N Anthony Coles · Director

$2.1M−76.0%Mar 6

CERESell

N Anthony Coles · Director

$2.1M−76.0%Mar 4

CERESell

John Renger · Chief Scientific Officer

$90K−25.0%Feb 8

CERESell

N Anthony Coles · Director

$104K−14.0%Feb 8

CERESell

N Anthony Coles · Director

$2.1M−95.0%Jan 4

CERESell

Ramiro Sanchez · Chief Medical Officer

$425K−41.0%Dec 28

CERESell

Kenneth Dipietro · CHRO

$332K−24.0%Dec 27

CERESell

Scott Akamine · General Counsel

$293K−49.0%Dec 21

CERESell

Mark Bodenrader · Insider

$327K−31.0%Dec 21

CERESell

Kenneth Dipietro · CHRO

$259K−20.0%Dec 21

CERESell

Ramiro Sanchez · Chief Medical Officer

$421K−41.0%Dec 21

CERESell

Susan Altschuller · CFO

$572K−45.0%Dec 21

CERESell

Kathleen Tregoning · Insider

$260K−46.0%Dec 21

CERESell

Ramiro Sanchez · Chief Medical Officer

$310K−100.0%Dec 19

CERESell

Ramiro Sanchez · Chief Medical Officer

$414K−100.0%Dec 11

CERESell

Scott Akamine · General Counsel

$676K−97.0%Dec 7

CERESell

N Anthony Coles · Director

$573K−89.0%Nov 16

CERESell

N Anthony Coles · Director

$680K−91.0%Nov 9

CERESell

N Anthony Coles · Director

$2.5M−97.0%Nov 6

CERESell

Deval L Patrick · Director

$753K−90.0%Nov 3

CERESell

N Anthony Coles · Director

$1.2M−95.0%Sep 8

CEREBuy

Ronald C Renaud Jr · President and CEO

$2.0MAug 7

CEREBuy

Paul D. Burgess · Insider

$502KAug 7

CERESell

N Anthony Coles · Director

$1.5M−95.0%Jul 13

CERESell

Marijn E Dekkers · Director

$6.9M−32.0%Jun 20

CERESell

N Anthony Coles · CEO and Chair

$1.6M−95.0%Jun 5

CERESell

Mark Bodenrader · Insider

$62K−26.0%Jun 5

CERESell

N Anthony Coles · CEO and Chair

$1.6M−95.0%May 8

CERESell

N Anthony Coles · CEO and Chair

$1.3M−95.0%Apr 13

CERESell

N Anthony Coles · CEO and Chair

$1.4M−95.0%Mar 6

CERESell

N Anthony Coles · CEO and Chair

$1.7M−95.0%Feb 8

CERESell

N Anthony Coles · CEO and Chair

$1.5M−95.0%Jan 6

CERESell

N Anthony Coles · CEO and Chair

$1.3M−95.0%Dec 13

CERESell

John Renger · Chief Scientific Officer

$750K−90.0%Nov 3

CERESell

John Renger · Chief Scientific Officer

$750K−90.0%Oct 6

CERESell

Deval L Patrick · Director

$1.5M−100.0%Sep 14

CERESell

Abraham Ceesay · President

$624K−100.0%Sep 12

CERESell

Abraham Ceesay · President

$312K−100.0%Aug 24

CEREBuy

Perceptive Advisors LLC · Director

$49.9M+28.0%Aug 18

CERESell

Abraham Ceesay · President

$328K−100.0%Aug 17

CERESell

John Renger · Chief Scientific Officer

$2.2M−95.0%Aug 12

CERESell

John Renger · Chief Scientific Officer

$750K−90.0%Jul 22

CERESell

John Renger · Chief Scientific Officer

$786K−91.0%Jul 7

CERESell

John Renger · Chief Scientific Officer

$1.6M−96.0%Apr 15

CERESell

John Renger · Chief Scientific Officer

$350K−83.0%Mar 31

CERESell

John Renger · Chief Scientific Officer

$1.4M−96.0%Mar 18

Older filings

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.